Hanmi Science Co Ltd 008930
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₩31,350.00
- Day Range
- ₩31,250.00–32,500.00
- 52-Week Range
- ₩25,750.00–56,200.00
- Bid/Ask
- ₩31,350.00 / ₩32,250.00
- Market Cap
- ₩2.18 Tril
- Volume/Avg
- 88,453 / 171,331
Key Statistics
- Price/Earnings (Normalized)
- 20.74
- Price/Sales
- 1.72
- Dividend Yield (Trailing)
- 0.93%
- Dividend Yield (Forward)
- 0.93%
- Total Yield
- 1.36%
Company Profile
Hanmi Science Co Ltd is a Korea-based holding company. The company through its subsidiaries manufactures and distributes pharmaceutical products. The company offers prescription drugs such as neuropathic pain, obesity, epilepsy, lactobacillus intestinal supplement, oral care, hair growth, anti-inflammatory, schizophrenia, smoking cessation aid, diabetes, osteoporosis, antiemetic, vaginal contraceptive, expectorants, ophthalmic, immunosuppressant, prostatism, cancer, antitussives, vitamins and nutritional supplements, constipation, dermatology, among others.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Mid Core
- Total Number of Employees
- 441
- Website
- http://www.hanmi.co.kr
Comparables
Valuation
|
Metric
|
008930
|
000100
|
039200
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.74 | 73.97 | — |
Price/Book Value | 2.62 | 5.39 | 16.71 |
Price/Sales | 1.72 | 5.83 | 315.84 |
Price/Cash Flow | 43.68 | 76.10 | — |
Price/Earnings
008930
000100
039200
Financial Strength
|
Metric
|
008930
|
000100
|
039200
|
|---|---|---|---|
Quick Ratio | 0.32 | 1.46 | 2.29 |
Current Ratio | 0.66 | 2.04 | 2.37 |
Interest Coverage | 13.66 | 14.13 | −131.58 |
Quick Ratio
008930
000100
039200
Profitability
|
Metric
|
008930
|
000100
|
039200
|
|---|---|---|---|
Return on Assets (Normalized) | 10.18% | 5.31% | −24.13% |
Return on Equity (Normalized) | 15.36% | 7.19% | −31.91% |
Return on Invested Capital (Normalized) | 13.04% | 6.38% | −34.10% |
Return on Assets
008930
000100
039200
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| Frhzwgfhg | Xlbwshq | $62.9 Bil | |||
| Cencora Inc
COR
| Fnbxsjy | Frkjcm | $43.1 Bil | |||
| Cardinal Health Inc
CAH
| Hknkjzlm | Crvjt | $27.1 Bil | |||
| Shanghai Pharmaceuticals Holding Co Ltd Class H
SHPMF
| — | Bbmlsy | $10.0 Bil | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H
SHPMY
| — | Kymnrgc | $10.0 Bil | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | Lqfdl | $9.1 Bil | |||
| Sinopharm Group Co Ltd
SHTDF
| — | Gwrrs | $9.1 Bil | |||
| Amplifon SpA Az nom Post Frazionamento
AMFPF
| — | Typyw | $6.4 Bil | |||
| Ebos Group Ltd ADR
EBOSY
| — | Mzhzblj | $4.5 Bil | |||
| Medipal Holdings Corp ADR
MAHLY
| — | Jldq | $3.7 Bil |
United States